MaxCyte, Inc. (MXCT) stock
MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3065% below fair value
$1.10−0.03 (-2.65%)
Close on Nov 11, 2026Market cap $113.53MP/E –Yield –
MaxCyte statistics
82 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 23, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.76
- 5.64
Enterprise valuationIndustry
- EV / Sales
- 0.36
- 1.67
Share statisticsIndustry
- Shares Change (YoY)
- -0.13%
- 1.01%
- Shares Change (QoQ)
- -2.73%
- 0.00%
- Float
- 95M
- 29M
- Shares Held by Insiders
- 8.01%
- 4.27%
- Shares Held by Institutions
- 61.3%
- 67.7%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -13.6%
- -4.60%
- Short % of Float
- 1.67%
- 5.23%
- Short % of Shares Outstanding
- 1.53%
- 3.31%
- Days to Cover
- 1.34
- 4.22
Stock price statisticsIndustry
- 52-Week High
- $1.80
- –
- 52-Week Low
- $0.64
- –
- 20-Day Moving Average
- $1.41
- –
- 50-Day Moving Average
- $1.26
- –
- 200-Day Moving Average
- $1.07
- –
- Average True Range (14)
- $0.14
- –
- Price Change (1 Week)
- -20.9%
- -1.60%
- Price Change (1 Month)
- 14.1%
- 0.00%
- Price Change (3 Months)
- -20.9%
- -7.29%
- Price Change (6 Months)
- 7.84%
- 1.20%
- Price Change (YTD)
- -29.0%
- -0.36%
- Price Change (1 Year)
- -25.2%
- -0.47%
- Price Change (3 Years)
- -66.6%
- -12.5%
- Price Change (5 Years)
- -91.2%
- -36.8%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 988,947
- –
- Relative Volume
- 2.18
- 0.70
- Relative Strength Index (14)
- 37.1
- 47.5
- Volatility (1 Year)
- 73.7%
- 62.9%
- Beta (5 Years)
- 1.53
- 0.83
MarginsIndustry
- Pretax Margin
- -81.4%
- 2.54%
- EBITDA Margin
- -86.5%
- 3.79%
- FCF Margin
- -62.4%
- 5.92%
Returns on capitalIndustry
- Return on Equity (ROE)
- -16.9%
- 1.76%
- Return on Assets (ROA)
- -14.1%
- -2.60%
- Return on Invested Capital (ROIC)
- -42.9%
- 5.25%
- Return on Capital Employed (ROCE)
- -20.2%
- 3.71%
Financial positionIndustry
- Current Ratio
- 7.83
- 1.36
- Quick Ratio
- 7.12
- 0.75
GrowthIndustry
- Revenue Growth (YoY)
- -0.13%
- 5.34%
- Revenue Growth (3Y CAGR)
- -9.30%
- 5.14%
- Revenue Growth (5Y CAGR)
- 4.76%
- 7.65%
EfficiencyIndustry
- Asset Turnover
- 0.17
- 0.82
- Inventory Turnover
- 0.87
- 13.10
- Revenue Per Employee
- $377.74K
- $215.67K
- Profits Per Employee
- -$307.50K
- -$534
- Employee Count
- 91
- 99
- WACC
- 12.5%
- 8.25%
Income statement (TTM)Industry
- Pretax Income
- -$27.98M
- -$31.25K
Balance sheetIndustry
- Net Cash (Debt)
- $101.28M
- $10.79K
- Net Cash Per Share
- $0.98
- $0.00
- Equity (Book Value)
- $150.93M
- $12.47M
- Book Value Per Share
- $1.46
- $0.73
- Tangible Book Value
- $150.18M
- $13.82K
- Working Capital
- $108.76M
- $4.10M
Cash flow (TTM)Industry
- Capital Expenditures
- -$424.00K
- -$7.86M
- FCF Per Share
- -$0.21
- $0.47
Dividends and yieldsIndustry
- Earnings Yield
- -24.6%
- 0.82%
- FCF Yield
- -18.9%
- 2.65%
Scores and fair valueIndustry
- Altman Z-Score
- 0.31
- 2.99
- Piotroski F-Score
- 2
- 5
- Beneish M-Score
- -2.73
- -2.75
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MXCT | S&P 500 | Difference | MXCT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.9% | -2.4% | +11.3 pts | ||
| 3 months | -11.3% | -1.2% | −10.1 pts | ||
| Year to date | -29.0% | +12.3% | −41.3 pts | ||
| 1 year | -29.0% | +12.4% | −41.5 pts | ||
| 3 years | -66.6% | +78.8% | −145.4 pts | -30.6% | +21.4% |
| 5 years | -91.5% | +75.2% | −166.6 pts | -38.9% | +11.9% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M MXCT shares were sold short on Oct 30, 2026, down 13.6% from the previous report, or 1.67% of the shares available to trade. At recent volumes it would take 1.3 days to buy them back. Over the last 20 sessions, 18.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,583,224 | -13.6% | 1,177,944 | 1.3 |
| Oct 15, 2026 | 1,831,817 | +68.1% | 1,714,275 | 1.1 |
| Sep 30, 2026 | 1,089,972 | -6.9% | 346,888 | 3.1 |
| Sep 15, 2026 | 1,170,407 | -10.1% | 417,192 | 2.8 |
| Aug 31, 2026 | 1,301,713 | +6.2% | 548,574 | 2.4 |
| Aug 14, 2026 | 1,225,669 | -1.4% | 1,087,660 | 1.1 |
| Jul 31, 2026 | 1,242,618 | -11.6% | 784,404 | 1.6 |
| Jul 15, 2026 | 1,406,444 | -7.2% | 1,151,692 | 1.2 |
| Jun 30, 2026 | 1,515,592 | -64.3% | 2,364,915 | 1.0 |
| Jun 15, 2026 | 4,239,514 | -5.2% | 734,485 | 5.8 |
| May 29, 2026 | 4,469,961 | -5.4% | 1,176,759 | 3.8 |
| May 15, 2026 | 4,724,376 | -9.9% | 1,254,248 | 3.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?